These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32942577)

  • 1. Production of Highly Active Recombinant Dermonecrotic Toxin of
    Stanek O; Linhartova I; Holubova J; Bumba L; Gardian Z; Malandra A; Bockova B; Teruya S; Horiguchi Y; Osicka R; Sebo P
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32942577
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Teruya S; Hiramatsu Y; Nakamura K; Fukui-Miyazaki A; Tsukamoto K; Shinoda N; Motooka D; Nakamura S; Ishigaki K; Shinzawa N; Nishida T; Sugihara F; Maeda Y; Horiguchi Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin.
    Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R
    Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
    McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD
    Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Bordetella dermonecrotic toxin with the extracellular matrix.
    Fukui-Miyazaki A; Kamitani S; Miyake M; Horiguchi Y
    BMC Microbiol; 2010 Sep; 10():247. PubMed ID: 20868510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and characterization of the dermonecrotic toxin gene of Bordetella bronchiseptica].
    Xue Y; Zhao Z; Pei J; Wang C; Ding K; Cheng X
    Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1722-8. PubMed ID: 22506412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
    Siniashina LN; Siniashina LS; Semin EG; Amelina IP; Karataev GI
    Mol Gen Mikrobiol Virusol; 2010; (3):31-6. PubMed ID: 20886687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine.
    Brockmeier SL; Register KB; Magyar T; Lax AJ; Pullinger GD; Kunkle RA
    Infect Immun; 2002 Feb; 70(2):481-90. PubMed ID: 11796573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms influencing expression of dermonecrotic toxin in Bordetella bronchiseptica.
    Okada K; Abe H; Ike F; Ogura Y; Hayashi T; Fukui-Miyazaki A; Nakamura K; Shinzawa N; Horiguchi Y
    PLoS One; 2015; 10(2):e0116604. PubMed ID: 25642712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of Bordetella pertussis toxins.
    Antoine R; Raze D; Locht C
    Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a receptor-binding domain of Bordetella dermonecrotic toxin.
    Matsuzawa T; Kashimoto T; Katahira J; Horiguchi Y
    Infect Immun; 2002 Jul; 70(7):3427-32. PubMed ID: 12065482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin.
    Schmidt G; Goehring UM; Schirmer J; Uttenweiler-Joseph S; Wilm M; Lohmann M; Giese A; Schmalzing G; Aktories K
    Infect Immun; 2001 Dec; 69(12):7663-70. PubMed ID: 11705946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathological effect of the Bordetella dermonecrotic toxin in mice.
    Magyar T; Glávits R; Pullinger GD; Lax AJ
    Acta Vet Hung; 2000; 48(4):397-406. PubMed ID: 11402657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases.
    Horiguchi Y
    Toxicon; 2001 Nov; 39(11):1619-27. PubMed ID: 11595625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases.
    Schmidt G; Goehring UM; Schirmer J; Lerm M; Aktories K
    J Biol Chem; 1999 Nov; 274(45):31875-81. PubMed ID: 10542213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets.
    Eliás B; Boros G; Albert M; Tuboly S; Gergely P; Papp L; Barna Vetró I; Rafai P; Molnár E
    Nihon Juigaku Zasshi; 1990 Aug; 52(4):677-88. PubMed ID: 2144027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella dermonecrotic toxin exerting toxicity through activation of the small GTPase Rho.
    Fukui A; Horiguchi Y
    J Biochem; 2004 Oct; 136(4):415-9. PubMed ID: 15625308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner.
    Matsuzawa T; Fukui A; Kashimoto T; Nagao K; Oka K; Miyake M; Horiguchi Y
    J Biol Chem; 2004 Jan; 279(4):2866-72. PubMed ID: 14597616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin.
    Masuda M; Minami M; Shime H; Matsuzawa T; Horiguchi Y
    Infect Immun; 2002 Feb; 70(2):998-1001. PubMed ID: 11796639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.